Literature DB >> 35614167

Nrf2 antioxidant pathway and apoptosis induction and inhibition of NF-κB-mediated inflammatory response in human prostate cancer PC3 cells by Brassica oleracea var. acephala: An in vitro study.

Mehri Nazeri1, Houshang Nemati2, Mozafar Khazaei1.   

Abstract

BACKGROUND: Brassica oleracea var. acephala is a good source of health-promoting biologically active compounds like phenolics, vitamins, and glucosinolates. METHODS AND
RESULTS: This in vitro research was conducted to evaluate the apoptotic, antioxidant, anti-inflammatory, and antiproliferative properties of ethanolic extract of Brassica oleracea var. acephala (EEBO) in PC3 prostate cancer cells. The LC-MS/MS technique was applied to identify the biomolecules of EEBO. The MTT assay was used to evaluate the cytotoxic effects of EEBO on PC3 cells. Moreover, qRT-PCR was used to examine the expression levels of Nrf2, NQO1, HO-1, NF-κB, TNF-α, IL-6, BAX, and BCL-2 in PC3 cell line. MMP was predicted by Rhodamine 123 staining, and release of cytochrome c was detected by an ELISA kit. Further, apoptosis was quantified by DNA fragmentation assay. The Western blotting method was used to detect the protein expression levels, and The DPPH assay was applied to determine the antioxidant effect of EEBO. The formula and structure of 19 biomolecules were predicted by LC-MS/MS. EEBO exhibited scavenging activity for DPPH. The MTT test showed EEBO reduced the viability of PC3 cells. The mRNA and protein levels of NRF2 pathway genes and BAX were increased, but those of the NF-κB pathway genes and BCL-2 were decreased in the EEBO-treated cells. Moreover, EEBO led to the diminution of MMP and enhanced the release of cytochrome c and DNA fragmentation, which resulted in apoptosis.
CONCLUSIONS: Molecular changes due to the anticancer impact of EEBO on PC3 were involved in the induction of Nrf2 antioxidant pathway and apoptosis and inhibition of inflammation.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Anti-inflammatory agents; Antioxidants; Apoptosis; Brassica oleracea var. acephala; NF-E2-Related factor 2; PC-3 cells

Mesh:

Substances:

Year:  2022        PMID: 35614167     DOI: 10.1007/s11033-022-07507-w

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  36 in total

Review 1.  Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer.

Authors:  R Ferraldeschi; C Pezaro; V Karavasilis; J de Bono
Journal:  Annu Rev Med       Date:  2012-09-27       Impact factor: 13.739

2.  Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1.

Authors:  Runyu Yang; Changqin Song; Jiaxi Chen; Lvqi Zhou; Xiubo Jiang; Xiaomei Cao; Yang Sun; Qi Zhang
Journal:  Phytomedicine       Date:  2020-03-20       Impact factor: 5.340

3.  Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.

Authors:  Wenji Li; Doug Pung; Zheng-Yuan Su; Yue Guo; Chengyue Zhang; Anne Yuqing Yang; Xi Zheng; Zhi-Yun Du; Kun Zhang; Ah-Ng Kong
Journal:  Chem Res Toxicol       Date:  2016-03-29       Impact factor: 3.739

Review 4.  Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.

Authors:  MaryBeth B Culp; Isabelle Soerjomataram; Jason A Efstathiou; Freddie Bray; Ahmedin Jemal
Journal:  Eur Urol       Date:  2019-09-05       Impact factor: 20.096

5.  Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin.

Authors:  Dong Xue; Cuixing Zhou; Yunbo Shi; Hao Lu; Renfang Xu; Xiaozhou He
Journal:  Oncotarget       Date:  2016-11-29

Review 6.  Controversy about pharmacological modulation of Nrf2 for cancer therapy.

Authors:  Lidija Milkovic; Neven Zarkovic; Luciano Saso
Journal:  Redox Biol       Date:  2017-04-08       Impact factor: 11.799

Review 7.  The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases.

Authors:  Wenjun Tu; Hong Wang; Song Li; Qiang Liu; Hong Sha
Journal:  Aging Dis       Date:  2019-06-01       Impact factor: 6.745

8.  α-Tocopheryl succinate pre-treatment attenuates quinone toxicity in prostate cancer PC3 cells.

Authors:  Ilaria Bellezza; Silvia Grottelli; Leonardo Gatticchi; Anna Lisa Mierla; Alba Minelli
Journal:  Gene       Date:  2014-02-12       Impact factor: 3.688

9.  ROS-independent Nrf2 activation in prostate cancer.

Authors:  Ilaria Bellezza; Paolo Scarpelli; Salvatore V Pizzo; Silvia Grottelli; Egidia Costanzi; Alba Minelli
Journal:  Oncotarget       Date:  2017-06-28

10.  Silencing of PYGB suppresses growth and promotes the apoptosis of prostate cancer cells via the NF‑κB/Nrf2 signaling pathway.

Authors:  Zhen Wang; Gang Han; Qinghong Liu; Wenyuan Zhang; Jinshan Wang
Journal:  Mol Med Rep       Date:  2018-08-14       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.